Prevention of reinfarction and sudden death.
There are many potential approaches to the prevention of reinfarction and sudden death, but the proof of benefit as yet is confined to the use of beta-adrenoceptor blocking drugs and coronary artery bypass surgery. In selected cases, aspirin, anticoagulants and antiarrhythmics drugs may prevent one or other of these complications, but other categories of drugs, including the calcium antagonists, seem at present unsuccessful. Greatest hope for the future lies in the development of strategies that limit infarct size.
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001792:Blood Platelets / Q000187:drug effects; D001026:Coronary Artery Bypass; D003645:Death, Sudden / Q000209:etiology; D006801:Humans; D009203:Myocardial Infarction / Q000209:etiology / Q000517:prevention & control*; D012008:Recurrence; D014693:Ventricular Fibrillation / Q000209:etiology
D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants